BETA ADRENERGIC RECEPTORS STIMULATION ATTENUATES PHOSPHORYLATION OF NF-κB AND IκBα IN HYPERGLYCEMIC ENDOTHELIAL CELLS

Contact Information

Wijaya Husada #16117
Sindang Barang, Kota Bogor

We're Available 24/ 7. Call Now.

BETA ADRENERGIC RECEPTORS STIMULATION ATTENUATES PHOSPHORYLATION OF NF-κB AND IκBα IN HYPERGLYCEMIC ENDOTHELIAL CELLS

Ikram Shah Bin Ismail

Keywords: : Beta Adrenergic receptors, Hyperglycemia-induced inflammation, Apoptosis NF-κB, HUVECs

Abstact

Background/Aims: NF-κB induces transcription of a number of genes, associated with inflammation and apoptosis. In this study, we have investigated the effect of β-adrenergic receptor stimulation on NF-κB and IκBα in HUVECs. Methods: Human umbilical vein endothelial cells (HUVECs) were cultured in high and low glucose concentrations. All HUVECs were treated with different concentrations of isoproterenol and propranolol for different time periods. The analytical procedures consisted of Western Blot, ELISA, DCFH-DA and TUNEL assays. Results: Isoproterenol (agonist of a betaadrenergic receptor) significantly reduced phosphorylation at Ser-536 of NF-κB; and Ser-32 and Ser-36 of IκBα in hyperglycemic HUVECs. Isoproterenol also significantly reduced apoptosis and ROS generation. No effect of IκBα was observed on Tyr-42 phosphorylation. The effect of isoproterenol was reversed by the antagonist propranolol. We also checked if NF-κB inhibitor MG132 causes any change at the level of apoptosis. However, we observed an almost similar effect. Conclusion: Given data demonstrates that beta-adrenergic receptors stimulation has a protective effect on HUVECs that might be occuring via NF-κβ and IκBα pathway.

References

1. Kolluru GK, Bir SC, Kevil CG: Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012 doi: 10.1155/2012/918267.
2 Batumalaie K, Safi SZ, Yusof KM, Ismail IS, Sekaran SD, Qvist R: Effect of Gelam Honey on the Oxidative Stress-Induced Signaling Pathways in Pancreatic Hamster Cells. Int J Endocrinol 2013 doi:10.1155/2013/367312.
3 Kumar, S. Safi SZ, Qvist R, Ismail IS: Effect of agonists of adenosine receptors on inflammatory markers in human Muller cells. Current Science 2014;106:582-586.
4 Safi SZ, Batumalaie K, Mansor M, Chinna K, Mohan S, Karimian H, Qvist R, Ashraf MA, Yan GO: Glutamine treatment attenuates hyperglycemia-induced mitochondrial stress and apoptosis in umbilical vein endothelial cells. Clinics (Sao Paulo) 2015;70:569-76 doi: 10.6061/clinics/2015(08)07.
5 Safi SZ, Qvist R, Ong G, Karimian H, Imran M, Shah I: Stimulation of β-adrenergic receptors plays a protective role via increased expression of RAF-1 and PDX-1 in hyperglycemic rat pancreatic islet (RIN- m5F) cells. Arch Med Sci 2017;13:470-480 doi: 10.5114/aoms.2016.64131.
6 Paramasivam D, Safi SZ, Qvis R, Abidin IBZ, Hairi NNM, Chinna K: Role of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients. Int J Diabetes Dev Ctries 2016;36:449–456.
7 Safi SZ, Shah H, Siok Yan GO, Qvist R: Insulin resistance provides the connection between hepatitis C virus and diabetes. Hepat Mon 2014;15:e23941 doi: 10.5812/hepatmon.23941 eCollection 2015.
8 Wild S, Roglic G, Green A, Sicree R, King H: Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. 9 Safi SZ, Qvist R, Chinna K, Ashraf MA, Paramasivam D, Ismail IS: Gene expression profiling of the peripheral blood mononuclear cells of offspring of one type 2 diabetic parent. Int J of Diabetes in Devel Ctries 2015 DOI: 10.1007/s13410-015-0369-1.
10 Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS: Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int 2014 doi: 10.1155/2014/801269.
11 Jansson PA: Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 2007; 262:173- 183.
12 Basha B, Samuel SM, Triggle CR, Ding H: Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress? Exp Diabetes Res 2012 doi: 10.1155/2012/481840.
13 Safi SZ, Qvist R, Yan GO, Ismail IS: Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genomics 2014;7:29.
14 Wang XM, Song SS, Xiao H, Gao P, Li XJ, Si LY: Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells. Cell Physiol Biochem 2014;34:658-671.
15 Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP: Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 2011;34: S285-290.
16 Manna P, Jain SK: Effect of PIP3 on adhesion molecules and adhesion of THP-1 monocytes to HUVEC treated with high glucose. Cell Physiol Biochem 2014;33:1197-1204.
17 Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
18 Li H, Cybulsky MI, Gimbrone MA, Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine- regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204.
19 Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009;1: a001651.
20 Garg A, Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002;16:1053-1068.
21 Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1999;16:225-260.
22 Reber L, Vermeulen L, Haegeman G, Frossard N: Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One 2009;4:e4393.
23 Wang D, Westerheide SD, Hanson JL, Baldwin AS: Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 2000;275:32592-32597.
24 Duran A, Diaz-Meco MT, Moscat J: Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 2003;22:3910-3918.
25 Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G: Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 2003;22:1313- 1324.
26 Zhong H, Voll RE, Ghosh S: Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998;1:661-671.
27 Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: IkappaB kinases phosphorylate NFkappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999;274:30353- 30356.
28 Walker RJ, Steinle JJ: Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Invest Ophthalmol Vis Sci 2007;48:5276-5281.
29 Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H: Indirect role of beta2-adrenergic receptors in the mechanism of anti-inflammatory action of NSAIDS. J Physiol Pharmacol 2008;59:661-672.
30 Peters K, Unger RE, Brunner J, Kirkpatrick CJ: Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 2003;60:49-57.
31 Gao SS, Shu S, Wang LJ, Zhou J, Yuan ZY: Pro-inflammatory and anti-inflammatory cytokine responses of peripheral blood mononuclear cells in apparently healthy subjects. Nan Fang Yi Ke Da Xue Xue Bao 2014;34:1589-1593.
32 Walker-Brown J, Roberts MR: Differential contribution of beta-adrenergic receptors expressed on radiosensitive versus radioresistant cells to protection against inflammation and mortality in murine endotoxemia. Shock 2009;32:541-547.
33 Kolmus K, Tavernier J, Gerlo S: beta-Adrenergic receptors in immunity and inflammation: Stressing NF- kappaB. Brain Behav Immun 2014 doi: 10.1016/j.bbi.2014.10.007.
34 Walker RJ, Anderson NM, Jiang Y, Bahouth S, Steinle JJ: Role of beta-adrenergic receptor regulation of TNF- alpha and insulin signaling in retinal Muller cells. Invest Ophthalmol Vis Sci 2011;52: 9527-9533.
35 Zapater P, Gomez-Hurtado I, Peiro G, Gonzalez-Navajas JM, Garcia I, Gimenez P, Frances R: Beta-adrenergic receptor 1 selective antagonism inhibits norepinephrine-mediated TNF-alpha downregulation in experimental liver cirrhosis. PLoS One 2012;7:e43371.
36 Nijhuis LE, Olivier BJ, Dhawan S, Hilbers FW, Boon L, Wolkers MC, de Jonge WJ: Adrenergic beta2 receptor activation stimulates anti-inflammatory properties of dendritic cells in vitro. PLoS One 2014;9:e85086.
37 Yao J, Hu R, Sun J, Lin B, Zhao L, Sha Y, Guo QL: Oroxylin A prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-kappaB signaling. Mol Carcinog 2014;53:145-158.
38 Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: IkappaB kinases phosphorylate NFkappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999;274:30353- 30356.
39 Song Y, Hong J, Liu D, Lin Q, Lai G: 1, 25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IkappaBalpha via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells. Scand J Immunol 2013;77:109-116.